New insight into the mechanism of action of and resistance to isoniazid: interaction of Mycobacterium tuberculosis enoyl-ACP reductase with INH-NADP.
作者信息
Argyrou Argyrides, Vetting Matthew W, Blanchard John S
机构信息
Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.
出版信息
J Am Chem Soc. 2007 Aug 8;129(31):9582-3. doi: 10.1021/ja073160k. Epub 2007 Jul 18.
Abstract
摘要
相似文献
1
New insight into the mechanism of action of and resistance to isoniazid: interaction of Mycobacterium tuberculosis enoyl-ACP reductase with INH-NADP.
J Am Chem Soc. 2007 Aug 8;129(31):9582-3. doi: 10.1021/ja073160k. Epub 2007 Jul 18.
2
Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
Chem Biol Drug Des. 2008 Nov;72(5):444-9. doi: 10.1111/j.1747-0285.2008.00722.x.
3
An inorganic iron complex that inhibits wild-type and an isoniazid-resistant mutant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
Chem Commun (Camb). 2004 Feb 7(3):312-3. doi: 10.1039/b313592f. Epub 2004 Jan 7.
4
Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
J Mol Biol. 2006 Jun 9;359(3):646-66. doi: 10.1016/j.jmb.2006.03.055. Epub 2006 Apr 21.
5
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance.
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13881-6. doi: 10.1073/pnas.2235848100. Epub 2003 Nov 17.
6
Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
Science. 1998 Jan 2;279(5347):98-102. doi: 10.1126/science.279.5347.98.
7
Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
J Struct Biol. 2007 Sep;159(3):369-80. doi: 10.1016/j.jsb.2007.04.009. Epub 2007 May 3.
8
Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
Bioorg Med Chem. 2007 Nov 1;15(21):6649-58. doi: 10.1016/j.bmc.2007.08.013. Epub 2007 Aug 15.
9
Recent progress in the identification and development of InhA direct inhibitors of Mycobacterium tuberculosis.
Mini Rev Med Chem. 2010 Mar;10(3):181-92. doi: 10.2174/138955710791185064.
10
Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
Mol Microbiol. 2000 Nov;38(3):514-25. doi: 10.1046/j.1365-2958.2000.02145.x.
引用本文的文献
1
Increased proportion of growth-arrested bacilli in acidic pH adaptation promotes treatment survival.
bioRxiv. 2025 Jul 14:2025.07.14.664820. doi: 10.1101/2025.07.14.664820.
2
Is Mycobacterial InhA a Suitable Target for Rational Drug Design?
ChemMedChem. 2025 Jul 1;20(13):e202500079. doi: 10.1002/cmdc.202500079. Epub 2025 Apr 29.
3
Tuberculosis vaccines and therapeutic drug: challenges and future directions.
Mol Biomed. 2025 Jan 22;6(1):4. doi: 10.1186/s43556-024-00243-6.
4
analyses of isoniazid and streptomycin resistance-associated mutations in .
Comput Struct Biotechnol J. 2023 Feb 21;21:1874-1884. doi: 10.1016/j.csbj.2023.02.035. eCollection 2023.
5
Tuberculosis: Past, present and future of the treatment and drug discovery research.
Curr Res Pharmacol Drug Discov. 2021 May 27;2:100037. doi: 10.1016/j.crphar.2021.100037. eCollection 2021.
6
Novel Assay Platform to Evaluate Intracellular Killing of : and Validation.
Front Immunol. 2021 Nov 12;12:750496. doi: 10.3389/fimmu.2021.750496. eCollection 2021.
7
Revisiting the methods for detecting : what has the new millennium brought thus far?
Access Microbiol. 2021 Aug 2;3(8):000245. doi: 10.1099/acmi.0.000245. eCollection 2021.
8
Isoniazid Killing of Mycobacterium smegmatis NADH Pyrophosphatase Mutant at Single-Cell Level using Microfluidics and Time-Lapse Microscopy.
Sci Rep. 2017 Sep 7;7(1):10770. doi: 10.1038/s41598-017-11503-7.
9
Dissecting the Structural Elements for the Activation of β-Ketoacyl-(Acyl Carrier Protein) Reductase from Vibrio cholerae.
J Bacteriol. 2015 Nov 9;198(3):463-76. doi: 10.1128/JB.00360-15. Print 2016 Feb 1.
10
In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatment.
Antimicrob Agents Chemother. 2015 Sep;59(9):5664-74. doi: 10.1128/AAC.05148-14. Epub 2015 Jul 6.
本文引用的文献
1
Proteome-wide profiling of isoniazid targets in Mycobacterium tuberculosis.
Biochemistry. 2006 Nov 28;45(47):13947-53. doi: 10.1021/bi061874m.
2
Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid.
Nat Struct Mol Biol. 2006 May;13(5):408-13. doi: 10.1038/nsmb1089. Epub 2006 Apr 30.
3
Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
Biochemistry. 2006 Apr 4;45(13):4131-40. doi: 10.1021/bi051967o.
4
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance.
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13881-6. doi: 10.1073/pnas.2235848100. Epub 2003 Nov 17.
5
Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
Mol Microbiol. 2002 Oct;46(2):453-66. doi: 10.1046/j.1365-2958.2002.03162.x.
6
Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2002 Jul;46(7):2137-44. doi: 10.1128/AAC.46.7.2137-2144.2002.
7
A fast and efficient metal-mediated oxidation of isoniazid and identification of isoniazid-NAD(H) adducts.
Chembiochem. 2001 Dec 3;2(12):877-83. doi: 10.1002/1439-7633(20011203)2:12<877::AID-CBIC877>3.0.CO;2-V.
8
Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis.
J Bacteriol. 2000 Jul;182(14):4059-67. doi: 10.1128/JB.182.14.4059-4067.2000.
9
Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
Science. 1998 Jan 2;279(5347):98-102. doi: 10.1126/science.279.5347.98.
10
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
Science. 1994 Jan 14;263(5144):227-30. doi: 10.1126/science.8284673.
Zotero 插件